Now Accepting New Patients, No Referral Needed: SCHEDULE NOW
Biologic therapy may be recommended for certain inflammatory or autoimmune conditions when symptoms remain active despite other treatments. These medications target specific parts of the immune system involved in inflammation.
PACT Rheumatology offers biologic infusion therapy in Connecticut for patients with autoimmune and inflammatory conditions requiring specialized treatment and monitoring.
Accepting New Patients
Biologics are targeted medications made from living cells. They work by blocking specific proteins or immune pathways that drive inflammation in certain autoimmune and inflammatory diseases.
Unlike older medications that affect the immune system more broadly, biologics are designed to act on specific parts of the immune response. They are commonly used for moderate-to-severe autoimmune conditions when traditional treatment is insufficient or poorly tolerated.
Biologic therapy for rheumatoid arthritis may be considered when joint inflammation remains active despite traditional treatment.
Some patients with psoriatic arthritis benefit from biologics that target inflammation affecting the joints, skin, tendons, or spine.
Biologic medications may be used for ankylosing spondylitis when inflammation contributes to ongoing back pain, stiffness, or reduced mobility.
For select patients with lupus, biologic therapy may be part of a broader treatment plan based on symptoms and disease activity.
Your rheumatologist will determine whether biologic therapy is appropriate based on diagnosis, prior treatments, lab results, and overall health.
Not sure which condition may be causing your symptoms?
Biologic infusion therapy is administered via IV in a supervised medical setting. The medication enters the bloodstream gradually while clinical staff monitors you during the appointment.
Your provider may review your diagnosis, medication history, lab results, infection risk, insurance authorization, and any preparation instructions.
You will be seated in a chair while the medication is administered via IV. Staff are available throughout the infusion to monitor comfort and answer questions.
Infusion length varies by medication and treatment plan. Your provider will explain what to expect before treatment begins.
Some patients may be monitored briefly after the infusion, especially when starting a new medication or if their provider recommends additional observation.
Your rheumatology team will review symptoms, lab results, and treatment response over time to determine whether adjustments are needed.
DMARDs, or disease-modifying antirheumatic drugs, are medications used to reduce inflammation and slow disease progression in autoimmune and inflammatory conditions.
Traditional DMARDs, such as methotrexate or hydroxychloroquine, affect the immune system more broadly. Biologics are a class of DMARDs that target specific immune pathways involved in inflammation.
Biologics may be considered when traditional DMARDs do not provide enough disease control or are not tolerated. In some cases, a biologic may be used along with a traditional DMARD as part of the treatment plan.
Biologic infusion therapy may be appropriate for patients with moderate-to-severe inflammatory disease that remains active despite traditional medication.
You may be evaluated for biologic therapy if you have:
Insurance approval is often required before starting biologic medications. PACT can help patients understand the steps involved in scheduling and authorization.
A biologic infusion appointment is designed to be supervised, organized, and connected to your rheumatology treatment plan.
Infusions take place in a medical environment where patients can sit comfortably while treatment is administered.
Biologic therapy is part of your ongoing rheumatology care, not a separate treatment disconnected from your condition management.
Clinical staff is available throughout the process to monitor your response and answer questions.
Appointments are coordinated based on your medication schedule, treatment plan, and insurance requirements.
Follow-up visits and lab work may be used to evaluate treatment response, side effects, and disease activity.
As part of Physicians Alliance of Connecticut, PACT Rheumatology can coordinate with other specialists when autoimmune disease affects multiple areas of health.
Your provider can review whether biologic therapy is appropriate, what to expect, and how the medication fits into your broader treatment plan.
Patients can receive biologic infusion therapy close to home through PACT Rheumatology without traveling to a large hospital system or out-of-state facility.
Interested in biologic therapy? Talk with PACT Rheumatology to learn whether it may be appropriate for your condition and treatment history.
Biologics are targeted medications used to reduce inflammation in certain autoimmune and inflammatory forms of arthritis. They work on specific parts of the immune system involved in disease activity.
Biologic infusion therapy is delivered through an IV in a supervised medical setting. The medication is given gradually while clinical staff monitors you during the visit.
Traditional DMARDs affect immune activity more broadly. Biologics are a type of DMARD that target specific immune pathways involved in inflammation. Your rheumatologist can determine which option fits your diagnosis and treatment history.
The length of a biologic infusion varies by medication and treatment plan. Some infusions may be shorter, while others may take longer. Confirm expected timing with your provider before your appointment.
Coverage depends on your insurance plan, diagnosis, medication, and prior authorization requirements. PACT can review scheduling steps and help patients understand what information may be needed.
Side effects vary by medication. Some biologics may increase the risk of infection or cause infusion reactions, so your provider will review the risks, benefits, and monitoring before treatment begins.
Yes. PACT Rheumatology provides specialist-supervised biologic infusion therapy in Connecticut as part of ongoing rheumatology care.
We use cookies to enable essential site functionality, analyze site traffic and user interaction, and personalize content. By clicking Accept, you consent to our use of cookies as described in our Privacy Policy.
PACT, LLC & PACT MSO, LLC
322 East Main Street, Suite 1B
Branford, CT 06405
PACT, LLC & PACT MSO, LLC
322 East Main Street, Suite 1B
Branford, CT 06405